GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Crescent Capital BDC Inc (FRA:487) » Definitions » Research & Development

Crescent Capital BDC (FRA:487) Research & Development : €0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Crescent Capital BDC Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Crescent Capital BDC's Research & Development for the three months ended in Mar. 2024 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0.0 Mil.

Crescent Capital BDC Research & Development Historical Data

The historical data trend for Crescent Capital BDC's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescent Capital BDC Research & Development Chart

Crescent Capital BDC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial - - - - -

Crescent Capital BDC Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Crescent Capital BDC Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crescent Capital BDC  (FRA:487) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Crescent Capital BDC Research & Development Related Terms

Thank you for viewing the detailed overview of Crescent Capital BDC's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescent Capital BDC (FRA:487) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Crescent Capital BDC Inc (FRA:487) » Definitions » Research & Development
Comparable Companies
HTD PFLT TRIN EOI VVR FAX FFC BOE ECC GGN BLK BX OSTO:INVE A TSX:BN KKR APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
CCAP:USA
Address
11100 Santa Monica Boulevard, Suite 2000, Los Angeles, CA, USA, 90025
Website
https://www.crescentbdc.com
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

Crescent Capital BDC (FRA:487) Headlines

No Headlines